Chris Markoch, Editor & Contributing Author at MarketBeat About Chris MarkochCTMarkoch@msn.comEditor & Contributing AuthorRetirement, Individual InvestingExperienceChris Markoch has been an editor & contributing writer for MarketBeat since 2018.Areas of ExpertiseValue investing, retirement stocks, dividend stocksEducationBachelor of Arts, The University of AkronPast ExperienceInvestorPlaceLearn About MarketBeat's Editorial Guidelines and Standards PolicyLatest Articles by Chris MarkochFebruary 8, 2024 5:00 AM ETWhy H&R Block Stock Looks More Attractive After Earnings DipChris MarkochH&R Block is down 9% after earnings; however, the dip in HRB stock will look more attractive as the company enters its two strongest quartersNYSE:HRBNYSE:GSRead Why H&R Block Stock Looks More Attractive After Earnings DipFebruary 7, 2024 5:00 AM ET3 best tech stocks to buy after earnings (that aren’t META)Chris MarkochIf you're looking for other tech stocks besides META to invest in, here are three tech stocks that are likely to provide strong growth in 2024.NASDAQ:METANASDAQ:NVDANASDAQ:AMDRead 3 best tech stocks to buy after earnings (that aren’t META)February 6, 2024 8:22 AM ETPalantir stock pops 20% and continues to silence skepticsChris MarkochPalantir stock gapped up 20% after a strong earnings report and improved guidance; history suggests a pullback is likely, but the company is quieting skepticsNYSE:PLTRNYSE:CRead Palantir stock pops 20% and continues to silence skepticsFebruary 6, 2024 8:13 AM ET3 small-cap biotechs with potential breakthroughs in 2024Chris MarkochThese small-cap biotech stocks feature large addressable markets combined with positive analyst sentiment and potential breakthroughs in 2024.NASDAQ:AMLXNASDAQ:PBYINASDAQ:SAVARead 3 small-cap biotechs with potential breakthroughs in 2024January 24, 2024 5:24 AM ETBuy any dip in GE stock even with uncertainty around the spinoffChris MarkochAfter issuing light guidance for Q1, investors should consider buying any dip in GE stock ahead of the spin-off of its Vernova power-generation businessNYSE:GERead Buy any dip in GE stock even with uncertainty around the spinoffJanuary 23, 2024 6:00 AM ET3 uranium stocks to buy as the metal hits 16-year highChris MarkochThe spot price of uranium is near 15-year highs and is forecast to go higher; it's not too late to take a long position in these three uranium stocks.NYSEAMERICAN:UECNYSE:CCJNYSE:BAMRead 3 uranium stocks to buy as the metal hits 16-year highJanuary 22, 2024 5:32 AM ETShould you follow the analysts’ lead on Birkenstock stock?Chris MarkochBirkenstock Holdings stock is stabilizing as analysts reassess the company's initial earnings report, but buyers may want to wait for BIRK stock to matureNYSE:BIRKNASDAQ:LULURead Should you follow the analysts’ lead on Birkenstock stock?January 16, 2024 5:35 AM ET3 Russell 2000 stocks for your January watchlistChris MarkochAs investors face another uncertain year in the market, it could be time to look at small- and mid-cap stocks; here are three Russell 2000 stocks to watchNASDAQ:CROXNYSE:BACNASDAQ:CHKRead 3 Russell 2000 stocks for your January watchlistJanuary 12, 2024 11:03 AM ETUnitedHealth Group Looks Buyable After AI-Fueled Double BeatChris MarkochUnitedHealth Group stock is falling after a double beat over concerns about rising medical costs; however, there’s another reason this may be a buyable dipNYSE:UNHRead UnitedHealth Group Looks Buyable After AI-Fueled Double BeatJanuary 12, 2024 4:33 AM ETIs Howmet Aerospace a buy after a bullish upgrade?Chris MarkochHowmet Aerospace stock is up more than 3% after getting a bullish upgrade and price target despite the recent incident surrounding Boeing's 737 Max 9 aircraftNYSE:HWMNYSE:BANYSE:TFCRead Is Howmet Aerospace a buy after a bullish upgrade?January 4, 2024 5:00 AM ET3 mid-cap stocks that analysts love heading into earnings seasonChris MarkochThe beginning of earnings season is a buying opportunity, here are three mid-cap stocks with a significant number of analyst upgrades in the last 90 days NASDAQ:CYBRNASDAQ:GTLBNASDAQ:WINGRead 3 mid-cap stocks that analysts love heading into earnings seasonDecember 19, 2023 5:20 AM ET3 Fitness Stocks Ready to Rally in the New YearChris MarkochThis is the time for New Year's resolutions, which makes it a good time to consider these three fitness stocks as additions to your portfolio in 2024NYSE:NKENYSE:GSNYSE:SKXRead 3 Fitness Stocks Ready to Rally in the New YearLatest Articles Reviewed by Chris MarkochFebruary 8, 2024 4:20 AM ET3 education stocks breaking out on a hiring spreeGabriel Osorio-MazilliThe time could be coming for professional traders and investors to focus on the educational industry; when they do, these three stocks deserve consideration NASDAQ:GOOGLNYSE:COURNYSE:DUOLRead 3 education stocks breaking out on a hiring spreeFebruary 8, 2024 4:10 AM ETRoblox is turning a corner, but can it complete a reversal?Thomas HughesRoblox is driving growth and leverage that is expected to continue in 2024; the stock is moving higher, but there are headwinds that may cap gains soonNYSE:RBLXRead Roblox is turning a corner, but can it complete a reversal?February 8, 2024 4:05 AM ETAlibaba stock earnings are out, everything just changedGabriel Osorio-MazilliThere is now another reason to take a second look at Alibaba stock, management just changed the entire game, and analysts could soon sweep with higher targetsNYSE:BABANYSEARCA:EWZNASDAQ:MCHIRead Alibaba stock earnings are out, everything just changedFebruary 7, 2024 4:30 AM ETAMD, Broadcom, Marvell, Nvidia: Big gainers from new AI spendingKate StalterChipmakers including AMD, Broadcom, Marvell and Nvidia are set to benefit from a surge in data center AI investment by tech titans such as Google and MicrosoftNYSE:BABANASDAQ:GOOGLNASDAQ:AMZNRead AMD, Broadcom, Marvell, Nvidia: Big gainers from new AI spendingFebruary 6, 2024 4:20 AM ET3 chemical stocks to play the industry breakoutGabriel Osorio-MazilliChemical stocks are calling for fundamental investor attention as they show a new breakout in the quarter; three stocks stand out as the best way to play itNYSEARCA:XLINYSE:MSNYSE:WFCRead 3 chemical stocks to play the industry breakoutFebruary 6, 2024 4:05 AM ETPepGen soars on Sarepta Therapeutics’ Duchenne drug phase 2 dataJea YuPepGen stock is moving higher on expectations of positive Phase 2 clinical trial results for its Duchenne muscular dystrophy (DMD) gene therapyNASDAQ:PEPGNASDAQ:SRPTRead PepGen soars on Sarepta Therapeutics’ Duchenne drug phase 2 dataFebruary 5, 2024 4:52 AM ETClorox cleans up after post-COVID normalization and a cyberattackJea YuClorox operations are back to normal after an August cyberattack, but the recent revenue surge may just be a one-time recovery event NYSE:CLXNYSE:PGNYSE:KMBRead Clorox cleans up after post-COVID normalization and a cyberattackFebruary 5, 2024 4:20 AM ETGoodyear Tires can benefit from EVs, but not how you may thinkJea YuThe Goodyear Tire and Rubber Company is benefiting from the more frequent replacement cycle required with electric vehicles, a trend that should remain in 2024NASDAQ:GTNASDAQ:TSLAOTCMKTS:PUGOYRead Goodyear Tires can benefit from EVs, but not how you may thinkFebruary 5, 2024 4:12 AM ETPayPal stock making a sudden turn, earnings breakout?Gabriel Osorio-MazilliPayPal management just made the latest move to push the company's profit margins higher, widening the gap potential for the stock to catch up to the sectorNASDAQ:CMENYSE:MANYSE:VRead PayPal stock making a sudden turn, earnings breakout?February 5, 2024 4:07 AM ET3 cheap utility stocks that shouldn't be so Gabriel Osorio-MazilliThe spill effects of the Red Sea conflicts may start affecting the utility sector, with these three stocks coming to offer stability and growth at discountsNYSE:BANYSE:AGRNYSE:AQNRead 3 cheap utility stocks that shouldn't be so February 5, 2024 4:02 AM ETTyson stock could see a boost in profits as costs normalizeGabriel Osorio-MazilliTyson stock could suddenly become the easiest buy for your portfolio this year; fundamental and technical factors have aligned for a new rallyNYSE:TSNNYSEARCA:XLPNYSE:MCDRead Tyson stock could see a boost in profits as costs normalizeFebruary 2, 2024 6:30 AM ETAlign Technology: Biting into growth, one aligner at a timeJeffrey Neal JohnsonAlign Technology's Q4 2023 showcases significant financial growth and strategic innovation in the dental and orthodontic solutions sectorNASDAQ:ALGNRead Align Technology: Biting into growth, one aligner at a timeVideos with Chris MarkochPalantir Stock Continues to Silence SkepticsPayPal a Fundamental Buying Opportunity in 2024?Microsoft Stock to $450? Here's HowAdvanced Micro Devices at Significant Turning PointThe Tesla Earnings Story That's NOT Being ToldWill Leverage and Pricing Power Drive Netflix to a Record High?Johnson & Johnson's Stock Price at Critical Turning PointA 50% Upside for AMD? Here’s HowBuffett Keeps Buying Occidental Petroleum, Should You?Upgraded Mid-Cap Stocks to Keep on Your RadarReports by Chris MarkochInvesting Strategies To Help Grow Your Retirement Income Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.